Voclosporin was found to be superior to standard-of-care treatment in patients with lupus nephritis, according to data from the phase 3 AURORA trial.
Researchers assessed the independent risk of hip fractures in patients with newly diagnosed systemic lupus erythematosus compared with the general population.
Researchers investigated and compared the rates, risks, and risk factors for atrial fibrillation among Medicaid recipients with systemic lupus erythematosus (SLE) and age- and sex-matched Medicaid recipients without SLE.
Although the first phase 3 trial of anifrolumab did not meet its primary end point, other study end points that were met suggested a clinical benefit for the monoclonal antibody in systemic lupus erythematosus.
Researchers addressed the association between cardiovascular risk and glucocorticoids in patients with systemic lupus erythematosus.
Researchers compared the rate of opioid overdose-related hospitalizations among patients with systemic lupus erythematosus and rheumatoid arthritis vs the general population.
Researchers examined the association of blood levels of hydroxychloroquine with thrombotic events in a longitudinal systemic lupus erythematous cohort.
Researchers studied cancer risk in patients with systemic lupus erythematosus and identified specific risk factors.
Researchers explored the effect of disease activity on specific health-related quality of life over time in patients with systemic lupus erythematosus, using the item response theory longitudinal model.
Researchers assessed the flare rate and predictors after immunosuppressant withdrawal in systemic lupus erythematosus remission.